LAM FOUNDATION

LAM is a rare and progressive lung disease that primarily affects women and has no known cure. Founded in 1995 as a grassroots effort, The LAM Foundation is the global leader in the fight against LAM. It has evolved into an organization that is described by the National Heart, Lung, and Blood Institute (NHLBI) as "a model for voluntary health agencies."... The LAM Foundation provides support and education for women with LAM and their families, engages doctors and scientists to continue to learn more about the disease, and raises funds for continued research. In May 2015, the FDA approved Rapamune as the first effective treatment for LAM, based on research and patient engagement supported by The LAM Foundation... For more than 25 years the LAM Foundation has provided hope and support to individuals facing this devastating rare disease. Our unwavering commitment is to empower our patient community and urgently drive research toward better treatments and a cure.

Also known as: The LAM Foundation

Primary location: Cincinnati United States